Wordt geladen...
Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs
Imepitoin is a novel anti-epileptic licensed in the European Union for the treatment of canine idiopathic epilepsy. The aim of this study was to characterize the pharmacokinetics of imepitoin in dogs and to evaluate the interaction with drug metabolizing enzymes. Upon administration of imepitoin tab...
Bewaard in:
| Gepubliceerd in: | J Vet Pharmacol Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280904/ https://ncbi.nlm.nih.gov/pubmed/24611573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvp.12117 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|